Clinical Trial Update: Pharmacogenomics of the Variability in the In Vivo Response to Glucocorticoids [Phase 1]

View source ↗

Summary

Phase 1 trial investigating pharmacogenomics behind variability in in vivo response to glucocorticoids; completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoids Toxicity
• Glucose Intolerance

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Glucocorticoids Toxicity, Glucose Intolerance | Phase 1 | Status: COMPLETED | Results posted: 2020-01-06